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Introduction
Collectively, breast cancers are the most common forms of cancer 
in women with over 1.676 million new diagnoses world-wide each year 
[1]. Since the introduction of national screening programmes, effective 
clinical staging, molecular diagnosis together with efficient treatment 
regimens, the survival of patients with breast cancer has improved 
significantly In the United Kingdom [1]. 
Radiotherapy is an important component of multimodal therapy 
for women with early stage (I and II) breast cancer [2]. In the UK 
all women should be offered radiotherapy following surgery or 
chemotherapy [3,4] and National Institute for Health Care Excellence 
(NICE) guidelines recommend fractionated radiotherapy of 40 Gy 
radiation in 15 fractions [5]. 
The intracellular protein kinase Brk (also known as breast tumor 
kinase or protein tyrosine kinase 6, PTK6) has been implicated in the 
development and progression of a number of different tumor types 
including breast cancer and is over-expressed in 80% of all types of 
breast cancer [6]. In this study we wished to determine the relationship 
between Brk oncogene over-expression and radiation sensitivity in 
breast cancer cell lines. Brk has been shown to be up-regulated and over-
expressed in up to 80% of ductal breast carcinomas but until recently 
was not thought to be expressed in normal breast tissue [7-9]. Brk is 
a non-membrane bound tyrosine kinase and has been demonstrated 
to interact with a number of key intracellular cell signalling proteins 
which lead to increased cell survival, enhanced cellular migration 
and elevated proliferation [7]; however, the impact of Brk expression 
on cellular radiation sensitivity and DNA DSB repair has not been 
evaluated. Previous studies do not reveal any direct link of Brk with 
DNA repair processes in breast cancer, although Brk expression has 
been linked to regulation of apoptosis in response to DNA damaging 
agents in non-tumor cells [9-11]. Also elevated Brk expression leads to 
increased ErbB signalling via PI3-K/AKT [12], an upstream activator 
of the mTOR (mammalian target of rapamycin) pathway [13]. PI3-K/
AKT/mTOR is considered as a potential therapeutic target in breast 
cancer [13]. Moreover, elevated mTOR signalling is known to suppress 
the ataxia telangiectasia mutated protein (ATM) expression by inducing 
microRNAs targeting ATM for destruction [14]. ATM is a key cell 
cycle regulator and mutational inactivation leads to extreme cellular 
and clinical sensitivity to radiation [15]. Thus we may hypothesise that 
increased Brk expression in breast cancer cells may affect the response 
of breast cancer cells to radiation via the ATM pathway. To examine 
the relationship between cellular response to ionising radiation and Brk 
expression in breast cancer cells we analysed the response of two groups 
of breast cancer cell lines. The triple negative breast cancer cell lines 
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Abstract
The breast tumor kinase (Brk) is over-expressed in 80% of all breast cancers and we sought to determine 
the influence of this oncogene on radiation sensitivity in breast cancer cell lines. Since radiotherapy is a routinely 
used method of treatment for early and intermediate stage breast cancer, the alteration of clinical radiosensitivity 
in breast cancer by an oncogene over-expression would have important implications in radiotherapy management. 
To address this question, we conducted an in vitro study of radiation sensitivity in two breast cancer cell lines, 
MDA-MB-157 and MDA-MB-468 transfected with cDNA constructs to over-express the following genes: Brk 
wild type (WT); Brk with an inactivating mutation in the kinase domain (KM) and vector only. Gamma H2AX foci 
assays by imaging flow cytometry were used to measure DNA double strand break (DSB) repair after radiation 
exposure. Total ataxia telangiectasia (ATM) and activated phospho794-ATM protein was measured by imaging 
flow cytometry. In all cell lines tested there was a proportionate decline in cell survival following gamma radiation 
exposure. Radiation sensitivity of the cell lines in clonogenic assays and repair of DNA double strand breaks were 
similar and independent of Brk expression status. We conclude that over-expression of the Brk proto-oncogene in 
breast cancer cell lines does not appear to influence radiation sensitivity or affect DNA DSB repair.
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MDA-MB-157 and MDA-MB-468 are derived from basal-type breast 
cancers and express low to undetectable levels of Brk [16,17]. These 
were transfected with plasmid vectors to over-express either the wild 
type Brk cDNA, a cDNA expressing a Brk protein with an inactivating 
mutation in the kinase domain of the protein (Brk-KM), or the empty 
plasmid vector. In the MDA-MB-157 cell line we observed significantly 
elevated cellular radiation resistance in the cells over-expressing the 
wild type Brk protein when compared to the cells transfected with the 
inactivated Brk-KM counterpart cDNA or the cells transfected with 
the empty plasmid vector. However, in the MDA-MB-468 cell lines, 
increased Brk expression was not associated with increased cellular 
resistance to radiation.
Materials and Methods
Transfected cell lines
Three variants each of the cell lines MDA-MB-157 and MDA-
MB-468 were used, namely –BRK-WT (containing the wild-type Brk 
cDNA), –BRK-KM (containing a mutated Brk cDNA), and –Vector 
(containing the empty vector pRc/CMV). The cell lines were originally 
obtained from ATCC, the transfections were carried out using 
Fugene-6 (Roche, Welwyn Garden City, UK) as part of our previous 
studies, and the stable cell lines were maintained in their usual culture 
medium supplemented with 400 µγ/µλ G418 (Melford Laboratories 
Ltd, Ipswich, UK) [9,18].
Cell culture
The cell lines were routinely cultured in T75 cell culture flasks 
(Sarstedt Ltd, Leicester, UK) in Dulbecco’s modiﬁed Eagle’s medium 
(MDA-MB-157 and MDA-MB-468) or RPMI-1640 (Lab Tech Ltd, 
East Sussex, UK) (T-47D, BT474, Sk-Br-3 for western blot analysis) 
supplemented with 10% foetal bovine serum, 2.0 mM L-Glutamine 
(Labtech) and 100 Uml−1 Penicillin and Streptomycin (Scientific 
Laboratory Supplies Ltd., Leicester, UK). GI101 cells were cultured 
in RPMI-1640 supplemented as described plus 5 μg/ml insulin 
(Sigma-Aldrich Ltd., Dorset, UK). MCF10A were routinely cultured 
in 1:1 HamsF12: DMEM (Life Technologies Ltd., Paisley, Scotland) 
supplemented with 10% foetal bovine serum, 2.0 mM L-Glutamine and 
100 Uml−1 penicillin and streptomycin plus 1 μg/ml hydrocortisone, 5 
ng/ml EGF and 5 μg/ml insulin (Sigma-Aldrich). 
Cells were incubated at 37°C in a humidified atmosphere of 5% 
CO2 in air. At approximately 80% confluence cells were routinely 
subcultured by trypsinisation in trypsin/EDTA solution containing 170 
U/ml trypsin, 0.2 mg/ml EDTA in phosphate buffered saline (Labtech).
Cell counts and viability were determined using a “Countess™” 
automated cell counter that utilises the trypan blue exclusion method 
(Life Technologies). Cells were not used for experimentation if overall 
viability was less than 80%. To minimise genetic drift in culture all cells 
were used over a restricted range of ten passages.
Clonogenic cell survival assays
Clonogenic assays post-exposure to gamma radiation were 
conducted as described previously [19]. Briefly, cells were suspended 
in appropriate complete medium and an aliquot retained as an un-
irradiated control. The remaining aliquots were irradiated with 
2, 4, 6 and 8 Gy gamma radiation from a 60Cobalt source (Puridec 
Technologies Ltd., Oxon, UK) sited at a distance of 25 cm from the 
source with a dose rate of 0.8 Gy per minute. Cells from the samples 
were plated into each of three 10 cm dishes, containing 10 ml DMEM 
complete medium. The cell suspension concentrations were: Control 
and 2 Gy (1000 cells/plate); 4 Gy (2000 cells/plate); 6 Gy (3000 cells/
plate); 8 Gy (4000 cells/plate). Cells were incubated for three weeks in a 
humidified atmosphere at 37°C with 5% CO2 in air, fixed in industrial 
methylated spirits, stained with 1.0% methylene blue in water (Sigma-
Aldrich). The number of colonies of greater than 50 cells was counted. 
The number of colonies derived from irradiated cells was expressed as 
a percentage of colonies in the un- irradiated control dishes.
DNA damage induction by gamma radiation exposure
Cells were plated into 10 cm dishes at concentrations of 2×106 
cells/dish (for the determination of DNA DSB by γ−Η2ΑΞ induction) 
and 4×106 cells/dish (for the identification of total or phosphorylated 
ataxia telangiectasia protein levels), and left overnight in an incubator 
(conditions described previously).
One dish of each cell line was retained as an un-irradiated control; 
the remaining dishes were irradiated with 2 Gy gamma radiation from 
a 60Cobalt source (Puridec) sited at a distance of 25 cm with a dose 
rate of 0.8 Gy per minute. Two Gray gamma irradiation was chosen to 
correspond to fractionated doses of radiation used in clinical protocols. 
We have also demonstrated previously that the induction of DNA DSB 
by 2 Gy gamma irradiation represents a region of maximal γ−Η2ΑΞ 
induction [20]. Following exposure the cells were returned to the 
incubator (incubation conditions described previously), and one dish 
removed at 30 minutes, 3 hours, 5 hours and 24 hours after irradiation.
Cells in each dish were harvested, washed once with ice-cold 
PBS (Severn Biotech Ltd., Worcestershire, UK) and fixed in ice-cold 
methanol:acetone (50:50 v/v). Two compensation samples for imaging 
flow cytometry were prepared in the same way at the 30 minute time-
point. Samples were stored at −20°C until the immunocytochemistry 
stage. The immunocytochemistry commenced within 5 days of 
irradiation.
Immunocytochemistry – gamma H2AX assay
Cells were re-suspended in ice-cold PBS then agitated gently for 5 
minutes at room temperature in permeabilisation buffer consisting of 
0.5% Triton™ X-100 (Sigma-Aldrich Ltd) in PBS. Cells were incubated 
with gentle agitation at room temperature for 1 hour in blocking 
buffer consisting of 5.0% rabbit serum (Labtech) with 0.1% Triton™ 
X-100 in PBS. After the removal of the blocking buffer the cells were 
incubated for 24 hrs with gentle agitation at 4°C in primary antibody 
solution, consisting of an anti-phospho-histone H2AX (serine139) 
mouse monoclonal IgG1 antibody, clone JBW301 (Millipore Ltd., 
Watford, UK) diluted 1 in 10,000 in blocking buffer. Excess primary 
antibody was removed by washing twice in buffer consisting of 0.1% 
Triton™ X-100 in PBS. Primary antibody labelled cells were incubated 
in secondary antibody solution consisting of Alexa Fluor®488 rabbit 
anti-mouse IgG antibody (Invitrogen) diluted 1 in 1000 in blocking 
buffer. This was added to each sample, except the DRAQ5™ (Biostatus 
Ltd., Leicester, UK) compensation samples, and incubated with gentle 
agitation for 1 hour at room temperature. Excess secondary antibody 
was removed by washing twice with wash buffer. The cells were re-
suspended in 100 μl. Accumax™ solution (Labtech) and left overnight 
at 4°C (no agitation). Five µΜ DRAQ5™ solution was added to each 
sample, except the AlexaFluor®488 compensation samples. The images 
of at least 10,000 cells for each time point were collected by imaging 
flow cytometry.
Determination of total and phosphorylated ataxia 
telangiectasia (ATM) mutated protein in the cell lines
To determine the relationship between Brk expression and total 
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and phosphorylated ATM protein in the breast cancer cell lines, cells 
were irradiated with 2 Gy gamma radiations (as described earlier). In 
un-irradiated cells and at 30 minutes after radiation exposure cells were 
fixed in 50:50 (v/v) ice-cold methanol:acetone. After rehydration of the 
cells and blocking in block buffer (as described for γ−Η2ΑΞ staining), 
cells were labelled with a primary antibody, either a mouse monoclonal 
antibody for the C-terminal region of the ATM protein (to detect total 
ATM), or a rabbit polyclonal for phosphorylated serine794 of the ATM 
protein (to detect phosphorylated ATM). Both primary antibodies 
(ECM Biosciences, 2B Scientific Ltd, Upper Heyford, Oxon, UK) were 
diluted 1 in 500 in blocking buffers, and the cells were incubated in the 
presence of the primary ATM antibody for 24 hrs at 4°C with gentle 
agitation. Following two 5 minute washes with wash buffer, cells were 
stained with either a rabbit anti-mouse or a goat anti-rabbit secondary 
antibody solution consisting of Alexa Fluor®488 IgG antibody diluted 
1 in 1000 in blocking buffer. This was added to each sample, except 
the DRAQ5™ compensation samples, and incubated with gentle 
agitation for 1 hour at room temperature. Cells were washed twice in 
wash buffer and left overnight at 4°C in Accumax™. Five micromole 
DRAQ5™ solution was added to each sample, except the AlexaFluor®488 
compensation samples.
Imaging flow cytometry
Imaging flow cytometry was carried out using the ImagestreamX 
system (Amnis Inc., Seattle, Washington, USA) as described previously 
[20,21]. Images of 10,000 cells were captured on channel 1 for brightfield 
(BF); on channel 2 for Alexa Fluor®488 (AF), depicting staining of 
γ-H2AX foci or ATM protein localisation; on channel 5 for DRAQ5™ 
(D5), depicting staining of the nucleus. Cell classifiers were applied to 
the BF channel to capture objects that represented only single cells, 
where an empirically determined scale of 50 as the lower limit and 300 
as the higher limit was used. Cellular fluorescence (γ-H2AX foci or 
ATM protein localisation) was detected by excitation with a 488 nm 
laser at a minimum power setting of 70 mW; all images were captured 
using a 40× objective lens. Images of cells were acquired at a rate of 100 
– 200 cell images per second.
Image compensation
Image compensation has been described in detail previously 
elsewhere [20,21]. In brief, cells that had been fixed 30 minutes post-
irradiation where γ−Η2ΑΞ staining or ATM protein staining intensity 
was likely to be highest were used to capture images of cells with the 
488 nm laser only and without brightfield illumination. Cells that were 
stained with antibody (Alexa Fluor488) only or DRAQ5™ only were 
used for generating the compensation matrix. The Ideas™ software 
compensation wizard produces a table of coefficients whereby detected 
light produced by each cellular image is placed into the proper channel 
(channel 2 for antibody staining and channel 5 for DRAQ5™) on a 
pixel-by-pixel basis. The coefficients were normalized to 1 and each 
coefficient represents the leakage of fluorescent signal into juxtaposed 
channels. Calculated compensation values were applied to all 
subsequent analyses as appropriate.
Analysis of cell images – calculation of gamma H2AX foci 
number in cells
Gamma-H2AX foci were quantified in approximately 10,000 
images of cells captured with the Inspire™ imaging flow cytometry 
software using a method described in detail elsewhere [8,12]. In brief, 
the spot counting wizard integral to the Ideas™ image analysis software 
was employed. Here a population of cells with very few foci (< 3) and 
very high foci numbers (>10) are user identified and then employed 
by the software to calculate the number of foci in each cellular image. 
From this analysis the average number of foci in all 10,000 cells can be 
determined.
Analysis of cell images – ATM protein staining in cells
To quantitate either the cellular level of total ATM or the 
phosphoserine784 ATM levels in irradiated and non-irradiated cells, 
the nuclear region of the cells was identified using the masking feature 
of the Ideas™ software programme. The intensity of Alexa Fluor488 
staining (total ATM or phosphoserine784 ATM) was calculated by 
determining the intensity of channel 2 staining within the nucleus. The 
mean levels of antibody staining here represent the ATM protein levels 
in these cells.
Statistical analysis
Statistical analysis was carried out using the data analysis feature 
in Microsoft Excel. Two-way analysis of variance was used to compare 
clonogenic cell survival following exposure to the sub-lethal dose of 2 
Gy gamma irradiation. Similarly, distribution of foci in cell lines post 
radiation exposure in the presence or absence of Brk expression was 
compared using the Student’s unpaired t-test, a p-value of < 0.05 being 
regarded as significant.
Western blotting
Cells were cultured until monolayers were 80% confluent, washed 
in PBS and harvested as described above. Following counting and 
centrifugation, cell pellets were lysed in 100 μl hot SDS-PAGE lysis 
buffer per 106 cells, boiled for 5 minutes and stored at −20ºC. Protein 
lysates equivalent to 1.5×105 cells were separated on a 10% SDS-
polyacrylamide gel and electro-blotted onto nitrocellulose membrane 
in 1x Towbin transfer buffer.
Membranes were blocked in 5% non-fat skimmed milk/TBS-T for 
1 hour and then incubated overnight at 4ºC in primary antibody in the 
same blocking buffer (anti-GAPDH – Abcam Ltd., Cambridge, UK) 
or in 5% BSA in TBS-T (anti-Brk – ICR100) [22]. Following washes 
in TBS-T, the proteins were visualised on film using an appropriate 
hrp-conjugated secondary antibody (Dako Ltd., Cambridge, UK) with 
chemiluminescent substrate.
Results
Clonogenic cell survival gamma radiation – MDA-MB-157 
cells
Figure 1A shows the survival of the cell lines following exposure to 
increasing doses of gamma radiation from a 60Cobalt source. Figure 
1A shows the survival of the MDA-MB- 157 cell lines expressing either 
Brk-WT, Brk-KM or an empty plasmid vector. For all cell lines there 
was a proportionate decline in cell survival following exposure to 
increasing doses of gamma radiation. In the Brk-WT cell line the cells 
were more resistant to the lethal effects of gamma radiation compared 
to Brk-KM and Vector cell lines. By comparing the SF2 values (the 
survival of the cells following exposure to 2 Gy gamma radiation), the 
Brk-WT cell lines displayed an SF2 of 75.35% +/- 7.62 standard error 
(SE). In the Brk-KM cell line the SF2 value was 50.56% +/- 0.39 SE and 
for the vector cell line the SF2 is 30.81 +/- 10.84 SE. Therefore the Brk-
WT cell line was 1.40 and 2.28 times more resistant to the lethal effects 
of gamma radiation than the Brk-KM and vector cell line variants 
respectively. By comparing the individual SF2 values from at least three 
replicate cell survival experiments, using a Student’s unpaired T-test, 
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the Brk-WT cell line was significantly more resistant to the gamma 
radiation than the Brk-KM and Vector cell lines (Student’s Unpaired 
t-test p>0.05).
Clonogenic cell survival gamma radiation – MDA-MB-468 
cells
In Figure 1B the survival of three MDA-MB-468 cell lines is shown. 
Similar to the MDA-MB-157 cell lines the MDA-MB-468 cell lines 
display a proportionate reduction in clonogenic cell survival following 
exposure to increasing doses of gamma radiation. Unlike the MDA-
MB-157 cell lines the MDA-MB-468 cells expressing Brk-WT or Brk-
KM have identical responses to the lethal effects of gamma radiation. 
Here the SF2 values for both cells lines were 60.03% +/- 8.03 SE for 
Brk-WT and 64.79% +/- 13.45 SE for the Brk-KM cell line. The MDA-
MB-468 vector cells exhibited an SF2 value of 40.84% +/- 8.81 SE. 
Therefore the Brk-WT and Brk-KM cells were 1.4 fold more resistant to 
the lethal effects of gamma radiation than the Vector cells. A Student’s 
unpaired t-Test used to compare the SF2 values for the MDA-MB-468 
cell lines shows that there is no significant difference in the survival of 
the Brk-WT and Brk-KM and vector only cell lines (p = 0.385).
Gamma-H2AX foci induction in the breast cancer cell lines
In Figures 2A and B the induction of γ−Η2ΑΞ foci in the MDA-
MB-157 (Figure 2A) and MDA-MB-468 cells lines (Figure 2B) is shown. 
Common to both cell lines irrespective of Brk expression status was the 
typical and rapid induction of DNA DSB revealed by a concomitant 
elevation of foci in the nuclei of cells. Then, over a 24 hrs period there 
was a reduction of foci to un-irradiated levels. In the MDA-MB-157 
cell line group there was a similar pattern of foci induction. We had 
originally hypothesised that the radiation resistant Brk-WT expressing 
cell line would reveal an altered DSB repair profile compared to the 
Brk-KM and Vector cell line variants. However, in three replicate 
experiments, the numbers of foci were not significantly different un-
irradiated cells for all three variants (p<0.05). Similarly at 30 minutes 
post irradiation, the point at which foci induction is maximal, there 
were similar levels of foci induction ranging between 5.9 +/- 0.78 SE 
and 7.84 foci +/- 1.90 SE which were not significantly different (p<0.05). 
Moreover, over the course of 24 hrs post irradiation the kinetics of 
DSB repair in the three cell line variants was not significantly different 
(p<0.05), and at 24 hrs after irradiation the number of foci in each of 
the three cell lines ranged from 3.46 +/- 0.52 SE for the Brk-WT and 
3.90 +/- 0.32 SE for the Vector cell line.
In the MDA-MB-468 group of cell lines a similar picture of DSB 
repair is shown. Typically at 30 minutes post-irradiation, there was a 
maximal induction of DSB revealed by high levels of foci number and 
this returned to normal un-irradiated levels at 24 hrs after irradiation. 
Again and in a similar manner to the MDA-MB-157 cell line group, 
there were no significant differences in the kinetics of repair of DSB 
over a 24 hrs period within the three cells lines irrespective of Brk 
functional status (p<0.05).
Total ATM and ATM phosphoserine794 in cells before and 
after exposure to 2 Gy gamma radiation
To determine if there was a functional relationship between total 
and phosphoserine794 ATM and Brk expression, the levels of both 
ATM protein variants were determined by immunological staining 
of total and phosphorylated ATM followed by analysis by imaging 
flow cytometry. For both total and ATM-phosphoserine794, the 
level of fluorescence in un-treated cells was compared to the levels in 
cells exposed to 2 Gy gamma radiation. We hypothesised that in cells 
Figure 1A and B: Show the clonogenic cellular sensitivity of the two breast 
cancer cell lines sets (Brk-WT, Brk-KM, Vector) to increasing doses of gamma 
radiation. Figure 1A shows the response of the MDA-MB-157 cell lines and 
Figure 1B shows the response of the MDA-MB- 468 cell lines. The data are 
derived from at least three independent experiments for each cell line. Error 
bars represent standard error of the mean cellular survival after exposure to 
2, 4, 6 and 8 Gy gamma radiations.
Figure 2A and B: Show the kinetics of DNA double strand break repair after 
exposure of the cells to 2 Gy gamma radiation. DSB were measure by nuclear 
γ-H2AX foci induction which is representative of DSB. γ-H2AX foci were 
measured in untreated cells and those exposed to 2 Gy gamma radiations 
at 0.5, 3, 5 and 24 hours post treatment. Figure 2A shows the data for the 
MDA-MB-157 cell lines and Figure 2B for the MDA-MB-468 cell lines. Data 
are derived from at least three independent experiments. Error bars show 
standard error of the mean foci induction at each time point.
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expressing the Brk-WT protein there would be altered levels of ATM 
and more importantly ATM-phosphoserine794 due to higher levels of 
functional Brk-WT protein.
The levels of total ATM for both the MDA-MB-157 and MDA-
MB-468 cells are shown in Figures 3A and B respectively. For the MDA-
MB-157 cell lines (Figure 3A) the level of fluorescence representing 
total ATM in un-irradiated cells is shown as a relative fluorescence of 
1.0. The amount of total ATM following 2 Gy gamma radiations was 
presented in comparison to the un-irradiated cells. In the Brk-WT 
cell lines the level of ATM slightly increased from 1.0 to 1.08 relative 
fluorescence. However in the Brk-KM and Vector cell lines there was a 
reduction of total ATM when compared to Brk-WT cells.
For the MDA-MB-468 cell lines (Figure 3B), there was a reduction 
in total cellular ATM following 2 Gy gamma radiation exposures in the 
Brk-WT and Brk-KM cells but levels were unchanged in the Vector 
cells.
The levels of phosphorylated ATM serine794 for both the MDA-
MB-157 and MDA-MB- 468 cells are shown in Figures 4A and 
B respectively. Interestingly, there seemed to be no relationship 
between phosphorylated ATM serine794 and overall cellular radiation 
sensitivity. Following 2 Gy exposures the levels declined in the MDA-
MB-157 Brk-WT and Brk-KM cell lines but increased in the Vector cell 
line (Figure 3A).
For phosphorylated ATM794 in the MDA-MB-468 cells, there were 
unchanged levels in the Brk-WT and Brk-KM cells after 2 Gy exposures 
when compared to untreated control cells. However in the Vector cell 
line there was a nearly 50% reduction in phosphorylated ATM794. The 
functional relevance of this data will be discussed.
Given that expression of WT-Brk decreased MDA-MB-157 cell 
sensitivity to radiation, we sought to determine whether Brk plays a 
role in radiation sensitive in a panel of breast cancer cells lines derived 
from different tumor types (Figure 5A and B). Clonogenic assays were 
carried out on all the cell lines, and their SF2 (the survival of the cells 
following exposure to 2 Gy gamma radiation) was calculated (Figure 
6 upper panel). Brk was detected in whole cell lysates from these cell 
lines by western blotting; however, there was no correlation between 
sensitivityand Brk expressions was observed (Figure 6 lower panel).
Discussion
In this report we have examined the influence of the Brk kinase on 
the radiosensitivity of cells lines derived from human breast cancer. 
We have also investigated the biochemical relationship between Brk 
Figure 3A and B: Show the total level of ATM protein in the cell lines in 
untreated cells and in those directly following their exposure to 2 Gy gamma 
radiations. Data are derived from analysing the nuclear intensity of fluorescent 
immunostaining of the ATM protein derived from imaging flow cytometry of at 
least 10,000 cells. Figure 3A shows the ATM protein in the MDA-MB-157 cell 
lines and Figure 3B for the MDA-MB-468 cell lines.
Figure 4A and B: Show the level of ATM phosphoserine794 protein in the 
cell lines before and after exposure to 2 Gy gamma radiations. Data are 
derived from analysing the nuclear intensity of fluorescent immunostaining 
of ATM phosphoserine794 protein derived from imaging flow cytometry of at 
least 10,000 cells. Figure 4A shows the ATM phosphoserine794 protein in the 
MDA-MB-157 cell lines and Figure 4B in the MDA-MB-468 cell lines.
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expression and the activity of the key cell cycle regulator ATM, which 
is central to the repair of DNA DSB.
The Brk kinase is an attractive target for study within the context 
of breast cancer treatment given that up to 85% of all invasive ductal 
breast cancers over-express Brk [23]. While Brk has been demonstrated 
to contribute to tumor progression via a number of mechanisms 
such as enhanced proliferation [18], elevated cancer cell migration 
and protection from autophagy [9], the role of Brk in mediating the 
response to cytotoxic radiotherapy has not been investigated. However, 
this is a pertinent enquiry vis-à-vis the potential modulation of ATM 
activity via Brk. Brk over-expression has previously been linked to 
enhanced ErbB signalling [8,23,14], a pathway with known links to 
radiation sensitivity [23]. Moreover it has been recently demonstrated 
that enhanced mTOR signalling in the context of childhood sarcoma 
mediated down-regulation of ATM by microRNA [22]. Thus it may 
be speculated that Brk over-expression may lead to breast cancer cell 
line hypersensitivity to radiation due to the lack of the G1 cell cycle 
checkpoint brought about by ATM deficiency. We examined the 
response of two basal-type cell lines, MDA-MB-157 and MDA-MB-468 
to increasing doses of radiation in a clonogenic assay. Each cell line had 
been transfected with a plasmid containing either a cDNA encoding 
either wild type Brk (Brk-WT), Brk with a mutation in the tyrosine 
kinase domain of the gene (Brk-KM) or the empty vector. In the MDA-
MB-157 Brk-WT cell line there was enhanced resistance to increasing 
doses of gamma radiation when compared to the Brk-KM and vector 
cell lines. By comparing the SF2 values (a sub-lethal dose) the wild-type 
Brk-expressing cell line was significantly more resistant than the other 
two counterpart cell lines (Student’s unpaired t-test p>0.05).
In the MDA-MB-468 cell lines the Brk-WT and Brk-KM cell 
lines exhibited similar radiation sensitivity and a comparison of 
the SF2 values for these cells lines revealed no significant difference 
in sensitivity (Student’s unpaired t-test p = 0.385). The difference in 
sensitivity between MDA-MB-468 and MDA-MB-157 in response to 
radiation in the presence of wild-type Brk could be explained, in part, 
by the signalling pathways activated in each parental cell lines. Despite 
both cell lines being characterised as triple negative [24], MDA-
MB-468 are known to have amplified levels of EGFR plus mutations 
in the PI3-K/AKT inhibitor PTEN [25]. Therefore addition of Brk may 
have little impact on a cell line with already elevated EGFR signalling. 
On the other hand the MDA-MB-157 cell line is not reported to have 
any abnormalities in EGFR signalling, suggesting that Brk expression 
would be more likely to impact on EGFR signalling in these cells. Given 
that EGFR signalling is linked to radiation responses, increased Brk 
might lead to increased survival of these cells in a kinase dependent 
manner.
In addition to analysing the radiation sensitivity in a clonogenic 
assay, we also sought to evaluate DNA DSB repair in the two cell 
line groups. Previous observations by our group and others reveal 
that hypersensitivity to ionising radiation is often associated with a 
defect or delayed repair of DSB. This is exemplified in cells derived 
from individuals with inherited mutations in genes controlling the 
recognition and repair of DNA double strand break repair. For 
example in A-T cells there is a deficiency in the repair of ionising 
radiation induced DSB shown by a persistence of γ−Η2ΑΞ foci in the 
nuclei of cells when compared to normal cells [21]. Based upon these 
observations, we might expect that the breast cancer cells lines in this 
study which are sensitive to radiation such as the MDA-MB-157 Brk-
KM and vector cell lines (when compared to the Brk-WT derivative), 
may exhibit a defect in the repair of DSB in the foci assay. We do observe 
induction of foci in all cell lines after radiation exposure, there are no 
significant differences in the kinetics of repair over a 24 hour period 
(p<0.05) and a similar pattern is observed with the MDA-MB-468 cells.
To determine if there was a potential link between Brk activity 
and ATM phosphorylation status in the cell lines we investigated 
the levels of total and phosphorylated forms of ATM in our six cell 
line derivatives. The principal phosphorylation site of ATM is the 
phosphoserine794 which is activated by proteins such as CDK5 and 
the auto-phosphorylation site serine1891 [26]. Our analysis of total 
ATM and phosphoserine794 ATM again revealed minor differences 
in the levels of both protein forms before and after exposure to 2 Gy 
Figure 5A and B: Show representative images of imaging flow cytometry 
of γ-H2AX foci staining (A) and total ATM staining (B). Three channels are 
presented whereby channel one represents the brightfield image; channel 
two the immune-labelled γ-H2AX foci or ATM protein and channel 5 shows 
the DRAQ5 staining of the nucleus within the cells.
Figure 6: Shows the levels of Brk expression related to SF2. Clonogenic 
assays were carried out to calculate the SF2 for each cell line (shown in the 
graph). Equal cell numbers were loaded onto an SDA-PAGE gel and Brk 
levels detected by western blotting (lower panels). Anti-GAPDH was used as 
a loading control.
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gamma radiations. Therefore this data suggests that there may be no 
direct molecular or biochemical link between Brk and ATM signalling.
Finally, having looked at Brk expression in relation to clonogenic 
survival following exposure to 2 Gy radiation, we found no direct 
correlation between Brk levels and cell survival. Combined with the 
data above, we hypothesise that the effect of Brk on radiation responses 
appears to be mediated by signalling outputs other than DSB repair.
In summary, we have conducted an investigation into the 
radiosensitivity of breast cancer cells lines over-expressing the Brk tumor 
kinase. We find no consistent alteration in cellular radiosensitivity in 
cells expressing either wild type or kinase-mutated Brk. Finally we do 
conceded that our study focussed on two sets of breasty cancer cell 
lines which have been genetically modified to over-express wild type 
or mutant Brk and a more comprehensive study of Brk expression 
and radiation sensitivity in more cell lines is required. Also a clinical 
study examining the response of breast cancers to radiotherapy vis- 
à-vis Brk expression would establish fully the relationship between Brk 
expression and radiotherapy.
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